Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 70 (2020): Issue 3 (September 2020)
Open Access
Differential effects of acute and chronic treatment with the flavonoid chrysin on anxiety-like behavior and Fos immunoreactivity in the lateral septal nucleus in rats
León Jesús Germán-Ponciano
León Jesús Germán-Ponciano
,
Abraham Puga-Olguín
Abraham Puga-Olguín
,
María De Jesús Rovirosa-Hernández
María De Jesús Rovirosa-Hernández
,
Mario Caba
Mario Caba
,
Enrique Meza
Enrique Meza
and
Juan Francisco Rodríguez-Landa
Juan Francisco Rodríguez-Landa
| Feb 17, 2020
Acta Pharmaceutica
Volume 70 (2020): Issue 3 (September 2020)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Feb 17, 2020
Page range:
387 - 397
Accepted:
Sep 04, 2019
DOI:
https://doi.org/10.2478/acph-2020-0022
Keywords
chrysin
,
anxiolytic
,
elevated plus maze
,
Fos protein
,
lateral septal nucleus
© 2020 León Jesús Germán-Ponciano et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
León Jesús Germán-Ponciano
Programa de Posgrado en Neuroetología Instituto de Neuroetología, Universidad Veracruzana
Xalapa
Laboratorio de Neurofarmacología Instituto de Neuroetología, Universidad Veracruzana
Xalapa
Abraham Puga-Olguín
Programa de Posgrado en Neuroetología Instituto de Neuroetología, Universidad Veracruzana
Xalapa
Laboratorio de Neurofarmacología Instituto de Neuroetología, Universidad Veracruzana
Xalapa
María De Jesús Rovirosa-Hernández
Instituto de Neuroetología, Universidad Veracruzana
Xalapa
Mario Caba
Centro de Investigaciones Biomédicas Universidad Veracruzana,
Xalapa
Enrique Meza
Centro de Investigaciones Biomédicas Universidad Veracruzana,
Xalapa
Juan Francisco Rodríguez-Landa
Laboratorio de Neurofarmacología Instituto de Neuroetología, Universidad Veracruzana
Xalapa
Facultad de Química Farmacéutica Biológica, Universidad Veracruzana
Xalapa